A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China
Objective: To understand the current situation of stigmatizing attitudes toward Coronavirus Disease 2019 (COVID-19) in China and compare it with acquired immunodeficiency syndrome (AIDS).Methods: Convenient sampling and vignette-based methods were used to recruit participants on WeChat. A demographi...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/792dadbeab88422e930e9d87e326cedd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:792dadbeab88422e930e9d87e326cedd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:792dadbeab88422e930e9d87e326cedd2021-12-01T22:50:00ZA Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China1664-064010.3389/fpsyt.2021.782501https://doaj.org/article/792dadbeab88422e930e9d87e326cedd2021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fpsyt.2021.782501/fullhttps://doaj.org/toc/1664-0640Objective: To understand the current situation of stigmatizing attitudes toward Coronavirus Disease 2019 (COVID-19) in China and compare it with acquired immunodeficiency syndrome (AIDS).Methods: Convenient sampling and vignette-based methods were used to recruit participants on WeChat. A demographic form and adopted stigma scale were used to collect participants' demographic information and stigmatizing attitudes toward COVID-19 and AIDS.Results: A total of 13,994 questionnaires were included in this study. A high portion of participants tend to avoid contact with individuals affected with COVID-19 (74.3%) or AIDS (59.0%), as well as their family members (70.4% for COVID-19 and 47.9% for AIDS). About half of the participants agreed that affected persons could not only cause problems to their own family but also have adverse effects on others (59.6% and 55.6% for COVID-19, 56.9 and 47.0% for AIDS). The agreements with statements about perceived stigma were similar but slightly higher than those about personal stigma in both COVID-19 and AIDS. Participants' agreements with all statements regarding personal and perceived stigma attitudes between COVID-19 and AIDS were all statistically significant (p < 0.001). Participants obtained COVID-19-related information mainly from social media (91.3%) and newspaper or television (77.1%) during the epidemic, and 61.0% of them thought information from newspapers or television was the most reliable.Conclusion: Several similarities and differences of people's attitude toward COVID-19 and AIDS were found. Avoidance, blame, and secondary discrimination to diagnosed persons and their surrounding persons were the main representations of COVID-19-related stigma. Stigma of COVID-19 had less moral link but more public panic. Experience from HIV-related stigma reduction and prevention can be applied to reduce COVID-19-related stigma.Manyun LiManyun LiJiang LongXuyi WangXuyi WangYanhui LiaoYueheng LiuYueheng LiuYuzhu HaoYuzhu HaoQiuxia WuQiuxia WuYanan ZhouYingying WangYingying WangYunfei WangYunfei WangQianjin WangQianjin WangYuejiao MaYuejiao MaShubao ChenShubao ChenTieqiao LiuTieqiao LiuFrontiers Media S.A.articleCOVID-19AIDSstigmaphysical avoidancepublic panicPsychiatryRC435-571ENFrontiers in Psychiatry, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
COVID-19 AIDS stigma physical avoidance public panic Psychiatry RC435-571 |
spellingShingle |
COVID-19 AIDS stigma physical avoidance public panic Psychiatry RC435-571 Manyun Li Manyun Li Jiang Long Xuyi Wang Xuyi Wang Yanhui Liao Yueheng Liu Yueheng Liu Yuzhu Hao Yuzhu Hao Qiuxia Wu Qiuxia Wu Yanan Zhou Yingying Wang Yingying Wang Yunfei Wang Yunfei Wang Qianjin Wang Qianjin Wang Yuejiao Ma Yuejiao Ma Shubao Chen Shubao Chen Tieqiao Liu Tieqiao Liu A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China |
description |
Objective: To understand the current situation of stigmatizing attitudes toward Coronavirus Disease 2019 (COVID-19) in China and compare it with acquired immunodeficiency syndrome (AIDS).Methods: Convenient sampling and vignette-based methods were used to recruit participants on WeChat. A demographic form and adopted stigma scale were used to collect participants' demographic information and stigmatizing attitudes toward COVID-19 and AIDS.Results: A total of 13,994 questionnaires were included in this study. A high portion of participants tend to avoid contact with individuals affected with COVID-19 (74.3%) or AIDS (59.0%), as well as their family members (70.4% for COVID-19 and 47.9% for AIDS). About half of the participants agreed that affected persons could not only cause problems to their own family but also have adverse effects on others (59.6% and 55.6% for COVID-19, 56.9 and 47.0% for AIDS). The agreements with statements about perceived stigma were similar but slightly higher than those about personal stigma in both COVID-19 and AIDS. Participants' agreements with all statements regarding personal and perceived stigma attitudes between COVID-19 and AIDS were all statistically significant (p < 0.001). Participants obtained COVID-19-related information mainly from social media (91.3%) and newspaper or television (77.1%) during the epidemic, and 61.0% of them thought information from newspapers or television was the most reliable.Conclusion: Several similarities and differences of people's attitude toward COVID-19 and AIDS were found. Avoidance, blame, and secondary discrimination to diagnosed persons and their surrounding persons were the main representations of COVID-19-related stigma. Stigma of COVID-19 had less moral link but more public panic. Experience from HIV-related stigma reduction and prevention can be applied to reduce COVID-19-related stigma. |
format |
article |
author |
Manyun Li Manyun Li Jiang Long Xuyi Wang Xuyi Wang Yanhui Liao Yueheng Liu Yueheng Liu Yuzhu Hao Yuzhu Hao Qiuxia Wu Qiuxia Wu Yanan Zhou Yingying Wang Yingying Wang Yunfei Wang Yunfei Wang Qianjin Wang Qianjin Wang Yuejiao Ma Yuejiao Ma Shubao Chen Shubao Chen Tieqiao Liu Tieqiao Liu |
author_facet |
Manyun Li Manyun Li Jiang Long Xuyi Wang Xuyi Wang Yanhui Liao Yueheng Liu Yueheng Liu Yuzhu Hao Yuzhu Hao Qiuxia Wu Qiuxia Wu Yanan Zhou Yingying Wang Yingying Wang Yunfei Wang Yunfei Wang Qianjin Wang Qianjin Wang Yuejiao Ma Yuejiao Ma Shubao Chen Shubao Chen Tieqiao Liu Tieqiao Liu |
author_sort |
Manyun Li |
title |
A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China |
title_short |
A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China |
title_full |
A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China |
title_fullStr |
A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China |
title_full_unstemmed |
A Comparison of COVID-19 Stigma and AIDS Stigma During the COVID-19 Pandemic: A Cross-Sectional Study in China |
title_sort |
comparison of covid-19 stigma and aids stigma during the covid-19 pandemic: a cross-sectional study in china |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/792dadbeab88422e930e9d87e326cedd |
work_keys_str_mv |
AT manyunli acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT manyunli acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT jianglong acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT xuyiwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT xuyiwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yanhuiliao acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuehengliu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuehengliu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuzhuhao acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuzhuhao acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT qiuxiawu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT qiuxiawu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yananzhou acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yingyingwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yingyingwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yunfeiwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yunfeiwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT qianjinwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT qianjinwang acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuejiaoma acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuejiaoma acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT shubaochen acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT shubaochen acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT tieqiaoliu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT tieqiaoliu acomparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT manyunli comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT manyunli comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT jianglong comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT xuyiwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT xuyiwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yanhuiliao comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuehengliu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuehengliu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuzhuhao comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuzhuhao comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT qiuxiawu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT qiuxiawu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yananzhou comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yingyingwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yingyingwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yunfeiwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yunfeiwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT qianjinwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT qianjinwang comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuejiaoma comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT yuejiaoma comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT shubaochen comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT shubaochen comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT tieqiaoliu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina AT tieqiaoliu comparisonofcovid19stigmaandaidsstigmaduringthecovid19pandemicacrosssectionalstudyinchina |
_version_ |
1718404047447261184 |